|4Jun 28, 12:27 PM ET

Sun BioPharma, Inc. 4

4 · Sun BioPharma, Inc. · Filed Jun 28, 2016

Insider Transaction Report

Form 4
Period: 2016-06-24
Kellen Scott
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2016-06-24+35,00035,000 total
  • Purchase

    Warrant (right to buy)

    2016-06-24+17,50017,500 total
    Exercise: $1.50From: 2016-06-24Exp: 2021-06-24Common Stock (17,500 underlying)
Footnotes (1)
  • [F1]Reported securities purchased as one share of common stock and one warrant to purchase one-half share of common stock for a combined price of $1.00 per "unit."

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    JUNE 2016 PIPE FORM 4